Digital PCR (dPCR) and qPCR Market - Forecast(2020 - 2025)

Report Code: HCR 0466 Report Format: PDF + Excel (Delivery in 48 Hrs)
Digital PCR (dPCR) and qPCR Market Overview
Digital PCR (dPCR) and qPCR Market size is forecast to reach $6.7 billion by 2025, growing at a CAGR of 7.9% during the forecast period 2020-2025. Polymerase Chain Reaction(PCR) is method widely used to make millions to billions of copies of a specific DNA sample which allow scientists to take a very small sample of DNA and amplify it to a large enough amount to study in detail. Digital PCR is a biotechnological refinement of conventional PCR methods that can be used to directly quantify and clonally amplify nucleic acids strands including DNA, cDNA, or RNA. A real-time polymerase chain reaction, also known as quantitative PCR, is a laboratory technique of molecular biology based on the PCR. With growing incidences of infectious disease and a greater number of advancement in PCR techniques are few of the factors driving the demand of Digital PCR (dPCR) and qPCR during the forecast period 2020-2025

Digital PCR (dPCR) and qPCR Market Report Coverage
The report: “Digital PCR (dPCR) and qPCR Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Digital PCR (dPCR) and qPCR Market.

By Technology: Quantitative PCR and Digital PCR
By Product: Reagents and Consumables, Instruments and Software
By Application: Clinical, Research Applications and Forensic Applications
By End Users: Hospitals and Diagnostic Centers, Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies, Clinical and Forensic Laboratories 
By Geography: North America, Europe, Asia-Pacific, and Rest of the World (RoW)

Key Takeaways
  • North America dominated the Digital PCR (dPCR) and qPCR Market in 2019 owing to the increase in research and developments by Pharmaceutical companies in this region.
  • Increase incidence of infectious diseases along with genetic disorders globally, Advancements in PCR techniques and research activities are few factors that are driving the growth of the Digital PCR (dPCR) and qPCR.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Digital PCR (dPCR) and qPCR Market report.

Product- Segment Analysis
Based on the Product, Digital (dPCR) and Real Time (qPCR) is segmented into Reagents and Consumables, Instruments and Software. In 2019, Reagents and Consumables held largest share of Product segment. This is owing to various applications of Quantitative PCR with respect to traditional PCR techniques. However, instruments are set to be the fastest growing CAGR among digital PCR (dPCR) during the forecast period 2020-2025. This is owing to reduced throughput time, elimination of reference standard and higher accuracy offered by dPCR with respect to qPCR. Also, the growing demand of forensic and drug discovery for digital PCR is also increasing the demand during the forecast period 2020-2025. 

Application-Segment Analysis
Based on the Application Digital (dPCR) and Real Time (qPCR) is segmented into Clinical, Research Applications and Forensic Applications. Research Applications holds highest share in 2019. This is owing to its application widely used for stem cell research, genetic and oncology research. However, Clinical segment is set to be fastest growing segment with a CAGR of 8.1% during the forecast period 2020-2025. This is owing to developments made in clinical laboratories and increase in adoption of automated process.

Geography-Segment Analysis
Based on the Geography Digital PCR (dPCR) and Real time PCR (qPCR) is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America accounted for largest market share of 41.15% in 2019 of overall market. This is owing to extensive R&D by Pharmaceutical companies in the region. Also, presence of maximum number of healthcare organization has attribute the demand of North America. However, Asia Pacific is set to be the fastest growing CAGR during the forecast period 2020-2025. This is owing to current expansion and modernization of healthcare infrastructure in countries such as China, India, and Japan. These countries are also increasing research projects in field of cancer, genomics, clinical research. Owing to these reasons the Digital PCR (dPCR) and qPCR is driving the demand in Asia Pacific countries.

Drivers- Digital PCR (dPCR) and qPCR Market
  • Rising incidences of Infectious and Genetic Disorders
In US, hospitals report well over 5 million cases of recognised infectious disease related illness annually. The use of PCR in infectious disease diagnosis, has resulted in an ability to diagnose early and treat disease owing to a fastidious pathogen, determine the antimicrobial susceptibility of slow growing organisms, and ascertain the quantum of infection. This in thus is creating advancement of PCR techniques and is driving the growth of market during the forecast period 2020-2025.

Challenges- Digital PCR (dPCR) and qPCR Market
Factors such as high cost of commercial PCR systems in clinical diagnostics, lack of awareness and requirement of skilled labor are some of challenges restraining the growth of market during forecast period 2020-2025. Also, technical limitations of PCR are restriction the growth of market.

Digital PCR (dPCR) and qPCR-Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Digital PCR (dPCR) and qPCR Market. In 2019, Digital PCR (dPCR) and qPCR Market share is consolidated by the top ten players present in the market. Digital PCR (dPCR) and qPCR top 10 companies are Thermo Fisher Scientific, Inc, F. Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc, Takara Bio, Inc., Agilent Technologies, Inc., BioMérieux S.A, Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA  among others. 

Acquisitions/Product Launches
On May 2020, Thermofisher Scientific announced the acquisition with Qiagen for $11.5 Billion. This acquisition is set to provide developments and advancements in Digital PCR.
1. Digital PCR (dPCR) and qPCR Market Overview
    1.1 Definitions and Scope
2. Digital PCR (dPCR) and qPCR Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key Trends by Product
    2.3 Key Trends by Application
    2.3 Key Trends by Geography
3. Digital PCR (dPCR) and qPCR Market – Comparative Analysis
    3.1 Product Benchmarking 
    3.2 Financial Analysis 
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Digital PCR (dPCR) and qPCR Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Digital PCR (dPCR) and qPCR Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Digital PCR (dPCR) and qPCR Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Digital PCR (dPCR) and qPCR Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Product Life Cycle
8. Digital PCR (dPCR) and qPCR Market – By Technology (Market Size –$Million/$Billion) 
    8.1 Quantitative PCR (qPCR)
    8.2 Digital PCR (dPCR) 
9. Digital PCR (dPCR) and qPCR Market – By Product (Market Size –$Million/$Billion)
    9.1 Reagents and Consumables
    9.2 Instruments
    9.3 Software
10. Digital PCR (dPCR) and qPCR Market – By Application (Market Size –$Million/$Billion)
    10.1 Clinical 
        10.1.1. Pathogen Testing
        10.1.2 Oncology Testing
        10.1.3 Blood Screening
        10.1.4 Others
    10.2 Research Applications
    10.3 Forensic Applications
11. Digital PCR (dPCR) and qPCR Market – By End Users (Market Size –$Million/$Billion)
    11.1 Hospitals and Diagnostic Centers
    11.2 Research and Academic Laboratories
    11.3 Pharmaceutical and Biotechnology Companies 
    11.4 Clinical Laboratories
    11.5 Forensic Laboratories
12. Digital PCR (dPCR) and qPCR Market - By Geography (Market Size-$Million/$Billion) 
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada 
    12.2 Europe
        12.2.1 Spain
        12.2.2 U.K
        12.2.3 France
        12.2.4 Italy
        12.2.5 Germany
        12.2.6 Rest of Europe
    12.3 Asia Pacific
        12.3.1 India
        12.3.2 China
        12.3.3 Japan
        12.3.4. South Korea
        12.3.5. Rest of Asia Pacific
    12.4 Rest of the World
        12.4.1 Africa
        12.4.2 Middle East
        12.4.3 South America
13. Digital PCR (dPCR) and qPCR Market - Entropy
14. Digital PCR (dPCR) and qPCR Market – Industry/Segment Competition Landscape (Premium)
    14.1 Market Share Analysis
        14.1.1 Global Market Share-Key Companies
        14.1.2 Market Share by Region-Key Companies
        14.1.3 Best Practices for Companies
15. Digital PCR (dPCR) and qPCR Market-Key Company List by Country Premium (Premium) 
16. Digital PCR (dPCR) and qPCR Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9 
    16.10 Company 10 and more